| |
|
- How can you assign a quantitative value to the information you can get from drug testing experiments?
- How can the results of in-vitro and in-vivo tests be extrapolated to human health?
- How can you capture the risks and opportunities associated with a key licensing project and structure optimal deal terms?
- How uncertain are your projections of costs and revenues?
The pharmaceutical & medical products industry is characterized by high risks & uncertainty throughout the business system. One estimate is that the pharmaceutical industry is as much as 50% riskier than the Standard & Poor’s (S&P) 500. And research by Tufts suggests that only one-third of new drugs recoup their R&D investment, a sobering fact given high attrition rates, long development times and a cost of $900M - $1.7B to bring a new drug to market. Even though potential rewards may be high - at least for the top 10% of drugs which traditionally have accounted for half the financial returns on all new drug development - companies are actively seeking viable alternatives to the blockbuster business model, given that the low-hanging fruit has been picked.
Vose Consulting’s expertise in pharmaceutical industry falls into three broad areas:
- Business strategy, including business development, project & portfolio management.
- Sales & Marketing planning - sales forecasting, detailing and sales force optimization.
- Epidemiology and clinical development – including clinical study design, safety and pharmacovigilance.
Click here to see more details on our capabilities.
Contacts
PhD, MBA, MSc
Toll Free (US) +1 866 259 7434
Tel +1 303 440 8524
Vose Consulting US Office
see map
top |
At Vose Consulting we believe in partnering relationships with our clients: that is, we strive to structure our clients' use of our time to maximize their benefit. To that end we prefer to work, wherever possible, alongside the client, demonstrating and teaching as we go the methods we use and sharing as much of the work as possible with the clients' personnel. This maximizes the transfer of knowledge, so that the client is better able to understand our work, and more capable of doing future projects by themselves. We aim for long-term relationships with our clients. To view the full list of our clients in this application, please follow the link at the end of the list “View All Clients”.
|
- Anacor Pharmaceuticals
- Astrazeneca
- bioStrategies Group, USA
- Eli Lilly
- J&J Ortho Biotech, USA
- Odyssey Pharmaceuticals
- Pfizer Inc, USA & Mexico
- Procter & Gamble Eurocor, Belgium
- Roche
- Johnson & Johnson, USA
- Accuray, USA
- Teva Neuroscience, USA
- GlaxoSmithKline (GSK)
- View all clients
|
|
top
Territory Optimization Model Problem: Pharma companies rely on reps to detail their products to physicians in assigned geographical territories. However, each territory may have different physicians populations, proportions of specialists, high prescribers, distances to travel, and market size. As rep salary is mostly based on actual performance, an equitable and efficient allocation of territories is key to the success of the promotion. The regional sales management for a large pharma company retained Vose Consulting to produce a tool for performing optimal territory assignment.
More
Problem : A large pharma company approached Vose to help evaluate the risks (and potential rewards) of a potential large and challenging licensing deal. The final contract would incorporate clauses allowing either party involved to change the business terms after signing.
More
Problem:
Vose Consulting was approached by a pharmaceutical firm who needed a sales forecasting application that would allow them to forecast sales for all drugs in the pipeline. The client wished not only to understand the expected sales of pipeline projects and drug candidates but also the uncertainty and risk surrounding sales.
More
|
View other example projects
top
Scheduled courses
Other courses
top
I have to tell you I have not seen this level of deep analysis from a third party so far. Congratulations!
Mr. Raul Melendez
Pfizer
It was a pleasure to work with the Vose team to build a revenue model for our pharmaceutical product candidates. They listened, hit our deadlines and produced a high-quality model on budget. Highly recommended!
Karin M Hold, PhD, Director of Business Development
Anacor Pharmaceuticals Inc.
View Other Quotes
top
|
|
|
